---
ticker: "ASD"
name: "Defiance Autism Impact ETF"
url: "https://etf.net/etf/ASD"
grade: "D"
score: 37
graded_at: "2026-10-12"
category: "Global Thematic"
category_rank: "17 of 21"
methodology: "https://etf.net/methodology"
---

# ASD: Defiance Autism Impact ETF

Grade **D**, Score 37 of 100. Rank 17 of 21 in Global Thematic.

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 10 | 19 of 21 |
| Mission | Not scored | — |
| Risk | 87 | 1 of 21 |
| Tradability | 22 | 19 of 21 |
| Holdings | 78 | 4 of 18 |
| Durability | 27 | 19 of 21 |

## Top holdings

The fund holds 41 positions. These are the largest 30, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | PKI | Revvity Inc | 3.43% |
| 2 | TEVA.TA | Teva Pharmaceutical Industries Ltd | 2.99% |
| 3 | ABBV | AbbVie Inc | 2.93% |
| 4 | PSON.L | Pearson PLC | 2.93% |
| 5 | MCOV-B.ST | Medicover AB | 2.92% |
| 6 | BTSG | BrightSpring Health Services Inc | 2.89% |
| 7 | BFAM | Bright Horizons Family Solutions Inc | 2.89% |
| 8 | LLY | Eli Lilly & Co | 2.86% |
| 9 | GHC | Graham Holdings Co | 2.85% |
| 10 | RGEN | Repligen Corp | 2.82% |
| 11 | LOPE | Grand Canyon Education Inc | 2.81% |
| 12 | ACHC | Acadia Healthcare Co Inc | 2.80% |
| 13 | 4502.T | Takeda Pharmaceutical Co Ltd | 2.78% |
| 14 | 4578.T | Otsuka Holdings Co Ltd | 2.78% |
| 15 | LRN | Stride Inc | 2.77% |
| 16 | NOVN.SW | Novartis AG | 2.76% |
| 17 | ROP.SW | Roche Holding AG | 2.74% |
| 18 | PFE | Pfizer Inc | 2.73% |
| 19 | SUPN | Supernus Pharmaceuticals Inc | 2.73% |
| 20 | 4506.T | Sumitomo Pharma Co Ltd | 2.73% |
| 21 | HLUN-B.CO | H Lundbeck A/S | 2.68% |
| 22 | JNJ | Johnson & Johnson | 2.67% |
| 23 | LHC.JO | Life Healthcare Group Holdings Ltd | 2.64% |
| 24 | GSK.L | Gsk PLC | 2.60% |
| 25 | NEU.AX | Neuren Pharmaceuticals Ltd | 2.59% |
| 26 | LFST | LifeStance Health Group Inc | 2.56% |
| 27 | DFTX | Definium Therapeutics Inc | 2.48% |
| 28 | 4507.T | Shionogi & Co Ltd | 2.48% |
| 29 | JAZZ | Jazz Pharmaceuticals PLC | 2.42% |
| 30 | BMY | Bristol-Myers Squibb Co | 2.40% |

Source: etf.net, https://etf.net/etf/ASD. Please cite the page URL.
